NERV
Price
$2.39
Change
-$0.04 (-1.65%)
Updated
Aug 25 closing price
Capitalization
16.71M
76 days until earnings call
RLFTY
Price
$3.32
Change
-$0.38 (-10.27%)
Updated
Aug 19 closing price
Capitalization
42.5M
Interact to see
Advertisement

NERV vs RLFTY

Header iconNERV vs RLFTY Comparison
Open Charts NERV vs RLFTYBanner chart's image
Minerva Neurosciences
Price$2.39
Change-$0.04 (-1.65%)
Volume$6.19K
Capitalization16.71M
RELIEF THERAPEUTICS HLDG AG
Price$3.32
Change-$0.38 (-10.27%)
Volume$155
Capitalization42.5M
NERV vs RLFTY Comparison Chart in %
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. RLFTY commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a StrongBuy and RLFTY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (NERV: $2.39 vs. RLFTY: $3.32)
Brand notoriety: NERV and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 22% vs. RLFTY: 17%
Market capitalization -- NERV: $16.71M vs. RLFTY: $42.5M
NERV [@Biotechnology] is valued at $16.71M. RLFTY’s [@Biotechnology] market capitalization is $42.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, both NERV and RLFTY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 6 TA indicator(s) are bullish while RLFTY’s TA Score has 4 bullish TA indicator(s).

  • NERV’s TA Score: 6 bullish, 4 bearish.
  • RLFTY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NERV is a better buy in the short-term than RLFTY.

Price Growth

NERV (@Biotechnology) experienced а -2.05% price change this week, while RLFTY (@Biotechnology) price change was -10.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +23.43%, and the average quarterly price growth was +29.28%.

Reported Earning Dates

NERV is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLFTY($42.5M) has a higher market cap than NERV($16.7M). NERV YTD gains are higher at: 7.580 vs. RLFTY (-32.245). NERV has higher annual earnings (EBITDA): 11.2M vs. RLFTY (-48.16M). NERV has more cash in the bank: 15.2M vs. RLFTY (10.7M). NERV has less debt than RLFTY: NERV (0) vs RLFTY (2.42M). RLFTY has higher revenues than NERV: RLFTY (8.59M) vs NERV (0).
NERVRLFTYNERV / RLFTY
Capitalization16.7M42.5M39%
EBITDA11.2M-48.16M-23%
Gain YTD7.580-32.245-24%
P/E Ratio1.61N/A-
Revenue08.59M-
Total Cash15.2M10.7M142%
Total Debt02.42M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERVRLFTY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
45%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAUHF121.841.78
+1.49%
Straumann Holding AG
FNNTF31.90N/A
N/A
FLATEXDEGIRO AG
MROPF0.13N/A
N/A
MICROPORT CARDIOFLOW MEDTECH CORP.
MQMIF0.07N/A
N/A
METALQUEST MINING INC.
KACLF13.05N/A
N/A
Kairous Acquisition Corp.

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
N/A
RLFTF - RLFTY
43%
Loosely correlated
-3.82%
ORKA - RLFTY
23%
Poorly correlated
-5.99%
PCVX - RLFTY
21%
Poorly correlated
-5.70%
HOTH - RLFTY
21%
Poorly correlated
-3.86%
NERV - RLFTY
21%
Poorly correlated
-1.85%
More